Herein, systemic AQP4 inhibition using TGN-020 (TGN) paradoxically exacerbates global glymphatic dysfunction despite alleviating cerebral edema and microcirculatory dysfunction following subarachnoid hemorrhage (SAH). The gene discussed is AQP4; the disease is subarachnoid hemorrhage.